These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22182575)

  • 21. Adenosine A1 receptor-dependent and -independent effects of the allosteric enhancer PD 81,723.
    Musser B; Mudumbi RV; Liu J; Olson RD; Vestal RE
    J Pharmacol Exp Ther; 1999 Feb; 288(2):446-54. PubMed ID: 9918544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and pharmacological evaluation of some 2-[4-morpholino]-3-aryl-5-substituted thiophenes as novel anti-inflammatory agents: generation of a novel anti-inflammatory pharmacophore.
    Pillai AD; Rathod PD; Xavier FP; Vasu KK; Padh H; Sudarsanam V
    Bioorg Med Chem; 2004 Sep; 12(17):4667-71. PubMed ID: 15358292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists.
    Ferguson GN; Valant C; Horne J; Figler H; Flynn BL; Linden J; Chalmers DK; Sexton PM; Christopoulos A; Scammells PJ
    J Med Chem; 2008 Oct; 51(19):6165-72. PubMed ID: 18771255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Amino-3-benzoylthiophene allosteric enhancers of A1 adenosine agonist binding: new 3, 4-, and 5-modifications.
    Lütjens H; Zickgraf A; Figler H; Linden J; Olsson RA; Scammells PJ
    J Med Chem; 2003 May; 46(10):1870-7. PubMed ID: 12723950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A
    Varano F; Catarzi D; Falsini M; Vincenzi F; Pasquini S; Varani K; Colotta V
    Bioorg Med Chem; 2018 Jul; 26(12):3688-3695. PubMed ID: 29880250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Romagnoli R; Preti D; Bovero A; Pineda de Las Infantas MJ; Moorman A; Varani K; Borea PA
    J Med Chem; 2004 Oct; 47(22):5535-40. PubMed ID: 15481989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Amino-3-aroyl-4,5-alkylthiophenes: agonist allosteric enhancers at human A(1) adenosine receptors.
    Tranberg CE; Zickgraf A; Giunta BN; Luetjens H; Figler H; Murphree LJ; Falke R; Fleischer H; Linden J; Scammells PJ; Olsson RA
    J Med Chem; 2002 Jan; 45(2):382-9. PubMed ID: 11784142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First structure-activity relationship study on dopamine D3 receptor agents with N-[4-(4-arylpiperazin-1-yl)butyl]arylcarboxamide structure.
    Leopoldo M; Lacivita E; Colabufo NA; Contino M; Berardi F; Perrone R
    J Med Chem; 2005 Dec; 48(25):7919-22. PubMed ID: 16335915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosteric enhancers of A1 adenosine receptors increase receptor-G protein coupling and counteract Guanine nucleotide effects on agonist binding.
    Figler H; Olsson RA; Linden J
    Mol Pharmacol; 2003 Dec; 64(6):1557-64. PubMed ID: 14645687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor.
    Romagnoli R; Baraldi PG; Moorman AR; Iaconinoto MA; Carrion MD; Cara CL; Tabrizi MA; Preti D; Fruttarolo F; Baker SP; Varani K; Borea PA
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5530-3. PubMed ID: 16931014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of long-term treatment with the allosteric enhancer, PD81,723, on Chinese hamster ovary cells expressing recombinant human A1 adenosine receptors.
    Bhattacharya S; Linden J
    Mol Pharmacol; 1996 Jul; 50(1):104-11. PubMed ID: 8700102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Derivatives of benzimidazol-2-ylquinoline and benzimidazol-2-ylisoquinoline as selective A1 adenosine receptor antagonists with stimulant activity on human colon motility.
    Cosimelli B; Taliani S; Greco G; Novellino E; Sala A; Severi E; Da Settimo F; La Motta C; Pugliesi I; Antonioli L; Fornai M; Colucci R; Blandizzi C; Daniele S; Trincavelli ML; Martini C
    ChemMedChem; 2011 Oct; 6(10):1909-18. PubMed ID: 21796795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor.
    Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Roerink SF; van den Hout G; Beukers MW; Brussee J; Ijzerman AP
    J Med Chem; 2005 Mar; 48(6):2045-53. PubMed ID: 15771447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of N-substituted 2-amino-4,5-diarylpyrimidines as selective adenosine A
    Alachouzos G; Lenselink EB; Mulder-Krieger T; de Vries H; IJzerman AP; Louvel J
    Eur J Med Chem; 2017 Jan; 125():586-602. PubMed ID: 27718474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current status of A1 adenosine receptor allosteric enhancers.
    Romagnoli R; Baraldi PG; Moorman AR; Borea PA; Varani K
    Future Med Chem; 2015; 7(10):1247-59. PubMed ID: 26144263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and structure-activity relationships of thieno[2,3-b]pyridin-4-one derivatives as a novel class of potent, orally active, non-peptide luteinizing hormone-releasing hormone receptor antagonists.
    Imada T; Cho N; Imaeda T; Hayase Y; Sasaki S; Kasai S; Harada M; Matsumoto H; Endo S; Suzuki N; Furuya S
    J Med Chem; 2006 Jun; 49(13):3809-25. PubMed ID: 16789738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, affinity profile, and functional activity of muscarinic antagonists with a 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine structure.
    Dei S; Bellucci C; Buccioni M; Ferraroni M; Guandalini L; Manetti D; Martini E; Marucci G; Matucci R; Nesi M; Romanelli MN; Scapecchi S; Teodori E
    J Med Chem; 2007 Mar; 50(6):1409-13. PubMed ID: 17305327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors.
    Romagnoli R; Baraldi PG; Remusat V; Carrion MD; Cara CL; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Balzarini J; Jordan MA; Hamel E
    J Med Chem; 2006 Oct; 49(21):6425-8. PubMed ID: 17034150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor.
    Bosch MP; Campos F; Niubó I; Rosell G; Díaz JL; Brea J; Loza MI; Guerrero A
    J Med Chem; 2004 Jul; 47(16):4041-53. PubMed ID: 15267242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.